SMITHBRIDGE ASSET MANAGEMENT INC/DE – Abbott Laboratories Transaction History
SMITHBRIDGE ASSET MANAGEMENT INC/DE portfolio value:
$4.24M
portfolio value
SMITHBRIDGE ASSET MANAGEMENT INC/DE quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.48% | 638 shares | -452K | $96.76 | 43.83K |
| Q2 2022 | share | Decrease | -0.05% | -20 shares | -422K | $108.65 | 43.19K |
| Q1 2022 | share | Decrease | -0.28% | -123 shares | -984K | $118.36 | 43.21K |
| Q4 2021 | share | Increase | +0.76% | 329 shares | 1.01M | $141 | 43.33K |
| Q3 2021 | share | Decrease | -0.95% | -411 shares | 47K | $117.68 | 43.00K |
| Q2 2021 | share | Increase | +2.12% | 900 shares | -62K | $115.05 | 43.41K |
| Q1 2021 | share | Increase | +2.95% | 1.22K shares | 573K | $118.49 | 42.51K |
| Q4 2020 | share | Decrease | -2.64% | -1.11K shares | -94K | $107.81 | 41.29K |
| Q3 2020 | share | Increase | +0.38% | 159 shares | 752K | $106.81 | 42.41K |
| Q2 2020 | share | Increase | +2.42% | 1K shares | 608K | $89.39 | 42.25K |
| Q1 2020 | share | Decrease | -1.81% | -761 shares | -394K | $76.84 | 41.25K |
| Q4 2019 | share | Decrease | -1.37% | -585 shares | 85K | $84.23 | 42.01K |
| Q3 2019 | share | Increase | +0.92% | 390 shares | 15K | $80.81 | 42.60K |
| Q2 2019 | share | Increase | +0.01% | 5 shares | 176K | $80.92 | 42.21K |
| Q1 2019 | share | Increase | +1.21% | 505 shares | 358K | $76.6 | 42.20K |
| Q4 2018 | share | Decrease | -0.85% | -358 shares | -70K | $68.98 | 41.70K |
| Q3 2018 | share | Increase | +3.93% | 1.59K shares | 618K | $69.69 | 42.06K |
| Q2 2018 | share | Decrease | -2.38% | -985 shares | -16K | $57.68 | 40.47K |
| Q1 2018 | share | Decrease | -3.43% | -1.47K shares | 34K | $56.4 | 41.45K |
| Q4 2017 | share | Increase | +1.73% | 732 shares | 198K | $53.46 | 42.92K |
| Q3 2017 | share | Decrease | -9.54% | -4.45K shares | -15K | $49.74 | 42.19K |
| Q2 2017 | share | Decrease | -3.52% | -1.7K shares | 120K | $45.07 | 46.64K |
| Q1 2017 | share | Decrease | -2.22% | -1.1K shares | 248K | $40.93 | 48.34K |
| Q4 2016 | share | 0.00% | 0 shares | -192K | $35.17 | 49.44K | |
| Q3 2016 | share | Increase | +3.34% | 1.59K shares | 210K | $38.48 | 49.44K |
| Q2 2016 | share | Increase | +1.48% | 700 shares | -91K | $35.55 | 47.85K |
| Q1 2016 | share | Decrease | -6.36% | -3.2K shares | -289K | $37.6 | 47.15K |